Single Incision Pelvic Floor Mesh Implants
1 other identifier
interventional
157
1 country
1
Brief Summary
Objectives: To evaluate whether the use of single incision un-anchored small mesh implants is feasible, safe and effective for women with moderate pelvic organ prolapse. Design: Patients diagnosed with moderate pelvic organ prolapse were enrolled to undergo a single incision un-anchored mesh operation. Follow-up was 4 to 23 months. The outcome measures for this study were the operative safety and post-operative pain, adverse effects and anatomical as well as functional cure. Setting: The operations were performed under general anesthesia according with the reported surgical techniques at university and private hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jul 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 24, 2013
CompletedFirst Posted
Study publicly available on registry
July 26, 2013
CompletedMay 5, 2016
July 1, 2013
4 months
July 24, 2013
May 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Operative mesh related complications
12 Months
Study Arms (1)
Single Incision Mesh
EXPERIMENTALintervention: single incision mesh implantation
Interventions
Single Incision Mesh is implanted for pelvic floor reconstruction
Eligibility Criteria
You may qualify if:
- \* Patients with Gr 2-3 Pelvic Organ Prolapse
You may not qualify if:
- \*Previous Pelvic irradiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assuta MC
Tel Aviv, 45320, Israel
Study Officials
- PRINCIPAL INVESTIGATOR
Menahem Neuman, Prof.
Western Galilee MC Nahariya
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2013
First Posted
July 26, 2013
Study Start
July 1, 2011
Primary Completion
November 1, 2011
Study Completion
February 1, 2012
Last Updated
May 5, 2016
Record last verified: 2013-07